This privacy policy (“Policy”) is issued on behalf of EUSA Pharma to let you know how companies within the EUSA Pharma Group collect and use your personal information. EUSA Pharma and the various entities of the EUSA Pharma Group (“EUSA Pharma”, “us”, or “we”) are committed to protecting your personal information.
This Policy does not apply to situations where we have notified you that an alternative privacy policy or notice applies to you.
This Policy applies to personal information which we receive from, or which relates to, our:
Where the personal information relates to your clients, employees, workers or contractors, you should bring this notice to their attention.
This Policy explains the type of personal information we collect and use, why we use the information, who we may need to share the information with, how we protect your personal information and your rights under applicable data protection laws.
We collect two types of information:
We collect your personal information directly in a variety of ways, including:
We also collect your personal information indirectly as set out below in “Information Received from Third Parties.”
EUSA Pharma collects your personal information for a variety of purposes depending on the nature of your relationship with us. The purposes for which we collect your personal information include:
If you fail to provide certain information when requested, we may not be able to provide our products and/or services to you.
We receive personal information about you from third parties such as:
As part of developing and testing new products and/or services, EUSA Pharma sponsors certain clinical trials in the EU, the United States and other jurisdictions from time to time. EUSA Pharma does not conduct clinical trials directly ourselves and any data which we receive in connection with clinical trials which we sponsor is anonymized and/or aggregated and is not personally identifiable. In the unlikely event that EUSA Pharma receives the personal information (which if received would likely include sensitive personal information) of participants in the clinical trials, we comply with all applicable laws in respect of it.
We do not sell, trade or rent your personal information to others. We may share anonymized information, i.e. aggregate data, with third parties. Except as described herein, we will not provide any of your personal information to any third parties without your specific consent.
We share your personal information with the following categories of recipient:
Your personal information will only be kept for as long as we reasonably consider necessary for achieving the purposes set out in this Policy or for as long as we are legally required to keep it.
When assessing the data retention period, we take into account the amount, nature, and sensitivity of the information, the potential risk of harm from unauthorized use or disclosure of the data, the purposes for which we process the data and whether we can achieve those purposes through other means, and the applicable legal requirements.
We have reasonable and appropriate security measures in place to protect against the loss, misuse, and alteration of any personal information we receive about you. We maintain appropriate security standards to protect the personal information that we maintain.
Cookies
We may obtain information, including personal information, about your general internet usage by using a cookie file which is stored on your browser or the hard drive of your device. Cookies contain information that is transferred to your device, which helps us to improve our website and to deliver a better and more personalized service to you. Some of the cookies we use are essential for the website to operate.
If you register with us, or if you continue to use our site, you agree to our use of cookies.
You may block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser setting to block all cookies (including essential cookies) you may not be to access all or parts of our websites. Unless you have adjusted your browser setting so that it will refuse cookies, our systems will issue cookies as soon you visit our websites.
Our website may use web analytics services like Google Analytics by Google, Inc. (“Google”), Mouseflow by Mouseflow, Inc., and Leadfeeder by Leadfeeder, Inc. These services use cookies to analyze use patterns and may collect information about your use of the website, including your IP address.
For more information about the web analytics services we may use, visit:
Google Analytics: https://policies.google.com/technologies/partner-sites
Mouseflow: https://mouseflow.com/privacy/
Leadfeeder: https://www.leadfeeder.com/privacy/
If you would like to opt-out of having your data used by the web analytics services, please:
- Google Analytics: visit https://tools.google.com/dlpage/gaoptout/.
- Mouseflow: visit https://mouseflow.com/opt-out/
- Leadfeeder: email privacy@leadfeeder.com
Please note that EUSA Pharma makes no representations regarding the functionality of Google, Mouseflow, and Leadfeeder opt-out mechanisms, and further, opting out of Google Analytics, Mouseflow, and Leadfeeder will not preclude the use of your data by other analytics services.
Third Party Websites
Except as otherwise provided in this Policy, this Policy only addresses the use and disclosure of information we collect from you. Other sites accessible through our websites have their own privacy policies and data collection, use, and disclosure practices. Please consult each site’s privacy policy as we are not responsible for the policies or practices of those sites or any third parties.
Do Not Track Mechanisms
California law requires this Policy to address how we respond to any “Do-Not-Track (“DNT”) signal” delivered by your browser. Because of the changing state of technology and indecision within the industry regarding the meaning of DNT signals, we currently do not make any guarantee that we will honor DNT signals.
You may have rights in relation to your personal information under applicable data privacy laws in other jurisdictions. If you wish to exercise any such rights, please contact us using the contact information below.
In relation to marketing communications, we may provide you with an “opt in” or “opt-out” mechanism depending on where in the world you are located. An “opt-in” mechanism will provide you the opportunity to positively indicate that you would like or do not object to our sending you such further communications and we will not send you any unless you have “optedin”. An “opt-out” mechanism will provide you the opportunity to indicate that you do not want us to send you such further communications, and if you “opt-out” we will not send you any.
We do not knowingly collect or use personal information from children under the age of [18]. If we determine that we have collected the information of an individual under this age, we will not use or maintain his or her personal information without parent or guardian consent. If we become aware that we have unknowingly collected personal information from a child under the age of [18], we will make reasonable efforts to delete such information from our records.
We strive to keep our records accurate and will make appropriate corrections when you notify us. Please let us know if there is incorrect information in any statements or other communications that you receive from us. If you would like to correct or update your personal information, please contact us using the contact details set out below.
The effective date of this Policy is posted above. We reserve the right to update or modify this Policy at any time by providing any notice required under applicable law and by providing you with the revised version in hardcopy, electronically or by otherwise making the revised version available on our websites.
If you have any questions about this Policy or if you would like to exercise any rights you may have in relation to your personal information, please contact us at: privacy@eusapharma.com.
EUSA US (US) LLC and its affiliates and subsidiaries (“EUSA,” “we,” “us,” or “our”) provide this California Employee Privacy Notice (the “CCPA Employee Privacy Notice”) to describe our privacy practices as required by the California Consumer Privacy Act of 2018 (“CCPA”).
This CCPA Employee Privacy Notice applies solely to employees, contract employees (“contractors”) and employee applicants who are California residents that meet the definition of consumer under the California Consumer Privacy Act of 2018 (CCPA) (“consumers” or “you”). We adopt this notice to comply with the CCPA, and any terms defined in the CCPA have the same meaning when used in this notice.
The CCPA is a comprehensive new consumer protection law that took effect on January 1, 2020. It requires companies to inform consumers about the personal information that they collect and share, and gives them a right to access their information, to request deletion of their information, and to opt-out of having their information sold.
Until January 1, 2021, employee personal information is outside of the scope of the CCPAvrequirements, except for:
This temporary exemption covers information collected in the course of the individual’s acting as a job applicant, employee, officer, director or contractor of EUSA, to the extent that EUSA uses such information in the context of the individual’s role (or former role) as an applicant, employee, etc. This includes emergency contact information and information necessary to administer benefits that an applicant, employee, etc. provides (which could include information about another individual who is the emergency contact or benefit recipient), so long as it is only used for that purpose.
The effective date of this Policy is posted above. We reserve the right to update or modify this Policy at any time by providing any notice required under applicable law and by providing you with the revised version in hardcopy, electronically or by otherwise making the revised version available on our websites.
Category | Examples of Data | Collected |
---|---|---|
A. Identifiers. | A real name, Internet Protocol address, email address, or other similar identifiers. | Yes |
B. Personal information categories listed in the California Customer Records statute (Cal. Civ. Code § 1798.80(e)). | A name, signature, Social Security number, physical characteristics or description, address, telephone number, passport number, driver’s license or state identification card number, insurance policy number, education, employment, employment history, bank account number, credit card number, debit card number, or any other financial information, medical information, or health insurance information. Some personal information included in this category may overlap with other categories. | Yes |
C. Protected classification characteristics under California or federal law. | Age, race, citizenship, marital status, medical condition, physical or mental disability, sex (including gender, gender identity, gender expression, pregnancy or childbirth and related medical conditions), veteran or military status. | Yes |
D. Commercial information. | Records of personal property, products or services purchased, obtained, or considered, or other purchasing or consuming histories or tendencies. | No |
E. Biometric information. | Genetic, physiological, behavioral, and biological characteristics, or activity patterns used to extract a template or other identifier or identifying information, such as, fingerprints, faceprints, and voiceprints, iris or retina scans, keystroke, gait, or other physical patterns, and sleep, health, or exercise data. | No |
F. Internet or other similar network activity. | Browsing history, search history, information on a consumer’s interaction with a website, application, or advertisement. | Yes |
G. Geolocation data. | Physical location or movements. | Yes |
H. Sensory data. | Audio, electronic, visual, thermal, olfactory, or similar information. | Yes |
I. Professional or employment-related information. | Current or past job history or performance evaluations. | Yes |
J. Non-public education information (per the Family Educational Rights and Privacy Act (20 U.S.C. Section 1232g, 34 C.F.R. Part 99)). | Education records directly related to a student maintained by an educational institution or party acting on its behalf, such as grades, transcripts, class lists, student schedules, student identification codes, student financial information, or student disciplinary records. | No |
K. Inferences drawn from other personal information. | Profile reflecting a person’s preferences, characteristics, psychological trends, predispositions, behavior, attitudes, intelligence, abilities, and aptitudes. | No |
Personal information does not include:
We obtain the categories of personal information listed above from the following categories of sources:
We may use or disclose the personal information we collect for one or more of the following business purposes:
We will not collect additional categories of personal information or use the personal information we collected for materially different, unrelated, or incompatible purposes without providing you notice.
We do not and will not sell your personal information and so we do not offer an opt-out to the sale of personal information.
We may share your personal information solely for a business purpose. When we disclose personal information for a business purpose, we enter a contract that describes the purpose and requires the recipient to both keep that personal information confidential and not use it for any purpose except performing the contract.
In the preceding twelve (12) months, we have disclosed the following categories of personal information for a business purpose:
Category A: Identifiers
Category B: California Customer Records personal information categories
Category C: Protected classification characteristics under California or federal law
Category F: Internet or other similar network activity.
Category G: Geolocation
Category H: Sensory
Category I: Professional or employment-related information
We disclose your personal information for a Business Purpose to the following categories of third parties:
In the preceding twelve (12) months, we have not sold or leased any personal information. EUSA does not sell or lease personal information.
We reserve the right to amend this privacy notice at our discretion and at any time. When we make material changes to this privacy notice, we will inform employees, update the notice’s Effective Date above and request employee acknowledgment by electronic review and sign-off.
If you have any questions about this Policy or if you would like to exercise any rights you may have in relation to your personal information, please contact us at: privacy@eusapharma.com or 908.552.9509.
SYLVANT® (siltuximab) is a prescription medicine used to treat people with multicentric Castleman’s disease (MCD) who do not have human immunodeficiency virus (HIV) and human herpesvirus-8 (HHV-8) infection. It is not known if SYLVANT is safe and effective in children.
Do not take SYLVANT if you have had a severe allergic reaction to siltuximab or any of the ingredients in SYLVANT. See the Medication Guide for a complete list of ingredients in SYLVANT.
Infections. SYLVANT may lower your ability to fight infections. Tell your healthcare provider right away if you have any signs or symptoms of an infection during treatment with SYLVANT.
Infusion and allergic reactions. If you have an infusion or allergic reaction while receiving SYLVANT, your healthcare provider will stop your infusion and treat your reaction. If you have a severe infusion or allergic reaction, your healthcare provider may stop your treatment completely. Tell your healthcare provider or get medical help right away if you have any of these symptoms during or after your infusion of SYLVANT:
rash, itching, upper respiratory tract infection, swelling, weight gain, and increased blood level of uric acid.
These are not all the possible side effects of SYLVANT. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Please see full Prescribing Information for additional Important Safety Information.
Please click “OK” to continue or “CANCEL” to return to SYLVANT.COM.
Please wait a moment.
The removal and examination of tissue, cells, or fluids from the body.
Powerful molecules that are normally secreted by the cells of the immune system in response to infectious or noninfectious agents.
An overreaction of the body’s immune system in which too many cytokines are released into the bloodstream very quickly, with potentially severe or life-threatening effects.
The underlying cause or origin of a disease is unknown.
Lymph nodes make immune cells that help the body fight infection.
A key signaling molecule that helps to regulate the body’s immune system.
A doctor who evaluates the changes caused by disease in tissues and body fluids and helps reach a diagnosis.
Administration of a drug solution into a vein.